Isatuximab | Interleukin Related interleukin-related.com

Product Name :
Isatuximab

Search keywords :
Nicotinamide

drugId :
null

Target Vo:
Lymphocyte differentiation antigen CD38

Target Vo Short Name :
CD38

Moa_Name:
Antibody-dependent cell-mediated cytotoxicity (ADCC) effects

First Approval Country :
United States

First Approval Date Filter:
2020

Origin Company_Name :
Immunogen Inc

Active Company_Name :
Assistance Publique Hopitaux De Paris

Active Indication_Name:
Multiple Myeloma

In Active Indication_Name:
Leukemia, T-Cell

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
NDA/BLA

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
c-Fos Antibody (YA506)
Survivin Antibody (YA045)
Cytokeratin 20 Antibody: Cytokeratin 20 Antibody is an unconjugated, approximately 44 kDa, rabbit-derived, anti-Cytokeratin 20 monoclonal antibody. Cytokeratin 20 Antibody can be used for: WB, IHC-P, ICC/IF, IP, FC expriments in human, rat background without labeling.

Author: Interleukin Related

Related Posts